Thyroid Artery Embolization for the Treatment of Compressive Goiters.

Summary

Very few studies have investigated TAE as a treatment for goiter with compressive symptoms. What is the efficacy and safety of TAE for the treatment of compressive goiters in a population ineligible for or refusing standard therapy? This is a prospective interventional cohort study that will allow us to standardize imaging by improving quality data collection and fellow-up to assess the efficacy of TAE for compressive symptoms of nodular goiters. Not only to corroborate current emerging results but clearly define the expected results for this technique.

Eligibility

Inclusion Criteria:

* Patient with compressive symptoms or significant tracheal or oesophageal compression at risk of causing symptoms attributed to a goiter AND
* Ineligible for surgery/ablative treatments or preference for TAE over other treatments AND
* TiRADS category 1, 2, 3 or 4 AND
* Bethesda categories I or III on 2 different biopsies OR Bethesda II on one biopsy AND
* Patient at least 18 years old.

Exclusion Criteria:

* Comorbidities precluding endovascular procedure OR
* TiRADS category 5 OR
* Bethesda categories IV, V, VI on biopsy OR
* Refusal of the patient to participate OR
* Uncontrolled severe hyperthyroidism OR
* Minor patient.

Conditions2

Browse More Trials